SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment
Abstract Background Septin 9 (SEPT9) interacts with multiple oncogenic proteins and is expressed abnormally in several cancers, including hepatocellular carcinoma (HCC). Plasminogen activator inhibitor-1 (PAI-1) promotes tumor formation and progression by modulating the tumor immune microenvironment...
Saved in:
| Main Authors: | Eundong Park, Xin Wang, Nusret Bekir Subasi, Michel Kmeid, Paul J. Higgins, Anne Chen, Hwajeong Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02252-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic accuracy of methylated SEPT9 for primary liver cancer: a systematic review and meta-analysis
by: Danwen Jin, et al.
Published: (2025-02-01) -
Methylation of SEPT9 and LINC00473 Genes in Circulating Cell-Free DNA as a Potential Biomarker for the Early Detection of Colorectal Polyps
by: Masoud Tat, et al.
Published: (2025-06-01) -
Comparative analysis of SDC2 and SEPT9 methylation tests in the early detection of colorectal cancer: a systematic review and meta-analysis
by: Jie Zhang, et al.
Published: (2024-12-01) -
Liquid biopsy of colorectal cancer: a new approach to evaluation of aberrant methylation of the <i>SEPT9</i> gene
by: I. V. Botezatu, et al.
Published: (2021-12-01) -
Association of <i>SEPT9</i> Gene Methylation with the Clinicopathologic Features and <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer Patients
by: Siew-Wai Pang, et al.
Published: (2025-04-01)